CAS: 139308-65-9 - Tolafentrine
Formula:C28H31N3O4S
InChI:InChI=1/C28H31N3O4S/c1-18-5-11-21(12-6-18)36(32,33)30-20-9-7-19(8-10-20)28-23-16-27(35-4)26(34-3)15-22(23)24-17-31(2)14-13-25(24)29-28/h5-12,15-16,24-25,30H,13-14,17H2,1-4H3/t24-,25-/m0/s1
- Synonyms:
- rel-(-)-N-[4-[(4aR,10bS)-1,2,3,4,4a,10b-Hexahydro-8,9-dimethoxy-2-methylbenzo[c][1,6]naphthyridin-6-yl]phenyl]-4-methylbenzenesulfonamide
- N-{4-[(4aS,10bR)-8,9-dimethoxy-2-methyl-1,2,3,4,4a,10b-hexahydrobenzo[c][1,6]naphthyridin-6-yl]phenyl}-4-methylbenzenesulfonamide
Benzenesulfonamide, N-[4-[(4aR,10bS)-1,2,3,4,4a,10b-hexahydro-8,9-dimethoxy-2-methylbenzo[c][1,6]naphthyridin-6-yl]phenyl]-4-methyl-, rel-(-)-
CAS:139308-65-9
Formula:
C28H31N3O4S
Color and Shape:
Solid
Molecular weight:
505.6284
Ref: IN-DA001AQ2
Undefined size | To inquire |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Ref: 4Z-T-137001
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Tolafentrine
Controlled ProductCAS:139308-65-9
Applications A dual-selective phosphodiesterase 3/4 inhibitor used in chronic experimental pulmonary hypertension. References Huxtable, R., …
Formula:
C28H31N3O4S
Color and Shape:
Neat
Molecular weight:
505.63
Ref: TR-T531000
2mg | 872.00 € | ||
5mg | 1,784.00 € | ||
500µg | 268.00 € |
Estimated delivery in United States, on Thursday 16 Jan 2025
Tolafentrine
CAS:139308-65-9
Tolafentrine is a drug used to treat chronic bronchitis and inflammatory bowel disease. It is …
Formula:
C28H31N3O4S
Purity:
Min. 98 Area-%
Color and Shape:
Powder
Molecular weight:
505.63 g/mol
Ref: 3D-FT28303
1mg | 986.00 € | ||
2mg | 1,392.00 € | ||
5mg | 2,551.00 € | ||
10mg | 4,637.00 € | ||
500µg | 582.00 € |
Estimated delivery in United States, on Tuesday 18 Feb 2025